Trial Profile
Efficacy and safety study of lacosamide in refractory focal onset epilepsy patients
Status:
Not stated
Phase of Trial:
Phase IV
Latest Information Update: 22 Feb 2016
Price :
$35
*
At a glance
- Drugs Lacosamide (Primary)
- Indications Epilepsy
- Focus Adverse reactions; Therapeutic Use
- 22 Feb 2016 New trial record